SCM
NEO icon

Semanteon Capital Management’s NeoGenomics NEO Stock Holding History

Semanteon Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-68,920
Closed -$956K – 270
2024
Q2 		$956K Buy
68,920
+48,813
+243% +$692K 0.68% 74
2024
Q1 		$316K Sell
20,107
-49,879
-71% -$770K 0.2% 167
2023
Q4 		$1.13M Buy
+69,986
New +$1.15M 0.76% 55

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Semanteon Capital Management's NEO Position: Q3 2024 in Review

Semanteon Capital Management sold out of NeoGenomics (NEO) in Q3 2024, closing a stake of 68,920 shares — an estimated $956K sold.

Semanteon Capital Management first reported a position in NEO in Q4 2023 and held it in 3 quarters. The position peaked at $1.13M in Q4 2023. 270 funds tracked by Wall St. Rank hold NEO as of Q3 2024.

  • Semanteon Capital Management reported no remaining NeoGenomics position as of Q3 2024 after selling out during the quarter.
  • Semanteon Capital Management sold 68,920 NeoGenomics shares in Q3 2024, an estimated $956K.
  • Semanteon Capital Management first reported a position in NeoGenomics in Q4 2023 and held it in 3 quarters.
  • Semanteon Capital Management's NeoGenomics position peaked at $1.13M in Q4 2023.
  • 270 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2024.

Based on Semanteon Capital Management's 13F filing for Q3 2024, filed 24 Oct 2024.